Targetable Biomimetic NIR-II Theranostic Nanoplatform for Highly Efficient Multimodal Imaging-Guided Photothermal Therapy of Cervical Cancer
Authors:
- Chenyang ChuCCChenyang Chu
- Zhong DuZDZhong Du
- Jing WangJWJing Wang
- Maierhaba AiliMAMaierhaba Aili
- Jiaxing LiJLJiaxing Li
- Jiabao XiongJXJiabao Xiong
- Rong MaRMRong Ma
- Cailing MaCMCailing Ma
- Nuernisha AlifuNANuernisha Alifu
Open Access
- 1 March 2026
- journal article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 21, 1-19
Abstract
Cervical cancer (CC) is still the fourth most common cause of cancer deaths in women. However, current biomedical imaging techniques exhibit inherent limitations in the diagnosis and treatment of CC. This study aims to develop a biomimetic nanoplatform based on tumor cell membranes, loaded with a palladium (Pd)-based computed tomography (CT) contrast agent and the near-infrared (NIR) fluorescent probe indocyanine green (ICG). This multifunctional nanoplatform is designed to integrate multimodal imaging with photothermal therapy (PTT), thereby improving the diagnostic accuracy and therapeutic efficacy against CC. In this study, biomimetic nanoparticles (NPs), designated as M@Pd-ICG NPs, were synthesized by encapsulating Pd and ICG within HeLa cell membranes derived from cell-derived xenograft (CDX) models. Subsequently, the toxicity, biocompatibility, and tumor suppression capability of the M@Pd-ICG NPs were evaluated in vitro. In vivo, the multimodal imaging performance of the M@Pd-ICG NPs and their photothermal therapeutic efficacy under 808-nm laser irradiation were investigated in mouse model bearing subcutaneous cervical tumor. The M@Pd-ICG NPs were successfully prepared and exhibited favorable stability, excellent photothermal conversion efficiency (34.04%), and good biocompatibility, enabling homologous targeting and prolonged circulation time. The M@Pd-ICG NPs integrated the complementary advantages of NIR-II fluorescence imaging (900–1700 nm, NIR-II FI), photothermal imaging (PTI), and CT imaging. Both in vitro and in vivo studies demonstrated that, under 808-nm laser irradiation, M@Pd-ICG NPs induced significant photothermal effects and tumor ablation. M@Pd-ICG NPs successfully integrate multimodal imaging and PTT, owing to their excellent targeting capability and good biocompatibility, demonstrating potential for further biomedical applications.Keywords
This publication has 45 references indexed in Scilit:
- An Anisotropic Gold‐Palladium Heterostructured Nanosystem for Synergistically Overcoming Radioresistance and Enhancing Melanoma RadioimmunotherapyAdvanced Science, 2025
- Advances in cervical cancer: current insights and future directionsCancer Communications, 2024
- Phototheranostic LPP‐QDs‐IR‐820 Nanocomposites for Specific NIR‐II Imaging of Lymphatic and Photothermal Therapy of Cervical TumorsAdvanced Healthcare Materials, 2024
- Palladium-based multifunctional nanoparticles for combined chemodynamic/photothermal and calcium overload therapy of tumorsColloids and Surfaces B: Biointerfaces, 2023
- Design and synthesis of cancer-cell-membrane-camouflaged hemoporfin-Cu9S8 nanoagents for homotypic tumor-targeted photothermal-sonodynamic therapyJournal of Colloid and Interface Science, 2023
- Liposomes containing nanoparticles: preparation and applicationsColloids and Surfaces B: Biointerfaces, 2022
- New indocyanine green therapeutic fluorescence nanoprobes assisted high-efficient photothermal therapy for cervical cancerDyes and Pigments, 2022
- A novel ICG-labeled cyclic TMTP1 peptide dimer for sensitive tumor imaging and enhanced photothermal therapy in vivoEuropean Journal of Medicinal Chemistry, 2022
- Synthesis and characterization of palladium nanoparticles by chemical and green methods: A comparative study on hepatic toxicity using zebrafish as an animal modelComparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 2021
- Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapyBiomaterials, 2017